Clinical Trials Directory

Trials / Conditions / Blood Disease

Blood Disease

49 registered clinical trials studyying Blood Disease4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingAlpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Related or Unrelated Donors for Blood Disea
NCT04806347
University of Wisconsin, MadisonPhase 1
Not Yet RecruitingRole of Transcranial Doppler and Magnetic Resonance Angiography for Future Management of Sickle Cell Anemia CN
NCT06498726
Eman Abdul-Hai
CompletedQIAstat-Dx® BCID Plus AMR Panels Clinical Performance Study
NCT05305534
QIAGEN Gaithersburg, Inc
UnknownThe Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)
NCT05983536
Qianfoshan Hospital
UnknownPopulation Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases
NCT05324917
The Affiliated Hospital of Qingdao University
UnknownEffect of Recombinant Human Bone Morphogenetic Protein-2 With an Absorbable Collagen Sponge on Stability of De
NCT05719181
University of BaghdadPhase 1
CompletedCentral Nervous System Disorders Following Hematopoietic Stem Cell Transplantation
NCT04737785
European Society for Blood and Marrow Transplantation
CompletedExamining the Experiences of Children With Blood Disorders
NCT04600609
University of Texas Southwestern Medical Center
UnknownCystatin c and Beta 2 Microglobulin in Thalassemic Children.
NCT03881917
Assiut University
CompletedThe Combination of IVIG, Dexamethasone and a Megadose of PBSCs for Decreasing DSAs
NCT06471478
Hematology department of the 920th hospital
UnknownUsing DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping
NCT03548766
Hamad Medical CorporationPhase 3
CompletedMedical Clowning: Needs Assessment and Implication for Hospitalized Children With Cancer/Blood Disease
NCT03586180
National Taiwan University Hospital
CompletedHPA Antibodies and the Distribution of Antigen and Antibodies
NCT03408158
Guangzhou First People's HospitalN/A
UnknownCollection and Distribution of Biospecimens for Novel Research
NCT05080907
iSpecimen Inc
RecruitingCollection and Distribution of Biospecimens for Novel Research Uses
NCT03848962
iSpecimen Inc
TerminatedPhase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Synd
NCT00486720
Merck Sharp & Dohme LLCPhase 2
RecruitingDiamond Blackfan Anemia Registry (DBAR)
NCT00106015
Northwell Health
CompletedPediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II
NCT00037388
National Heart, Lung, and Blood Institute (NHLBI)
CompletedTranscranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUG
NCT00059293
National Heart, Lung, and Blood Institute (NHLBI)
CompletedPain in Sickle Cell Epidemiologic Study
NCT00035763
Virginia Commonwealth University
CompletedBlood and Marrow Transplant Clinical Research Network
NCT00023530
National Heart, Lung, and Blood Institute (NHLBI)N/A
CompletedInduction of Stable Chimerism for Sickle Cell Anemia
NCT00029393
National Heart, Lung, and Blood Institute (NHLBI)Phase 2
CompletedStroke Prevention in Sickle Cell Anemia (STOP 2)
NCT00006182
National Heart, Lung, and Blood Institute (NHLBI)Phase 3
CompletedHemochromatosis and Iron Overload Screening Study (HEIRS)
NCT00005541
National Heart, Lung, and Blood Institute (NHLBI)
CompletedHepatitis C in Clinically Discordant Hemophilic Siblings
NCT00007371
University of North Carolina, Chapel Hill
CompletedHemochromatosis--Genetic Prevalence and Penetrance
NCT00006312
University of Rochester
CompletedCytomegalovirus Spread and Reactivation in Blood Cells
NCT00006314
National Heart, Lung, and Blood Institute (NHLBI)
CompletedEpidemiology and Immunology of Hemophilia A Inhibitors
NCT00005518
National Heart, Lung, and Blood Institute (NHLBI)
CompletedStatistical Basis for Hemochromatosis Screening
NCT00005559
National Heart, Lung, and Blood Institute (NHLBI)
CompletedRetention of Bone Marrow Donors in a National Registry
NCT00005556
National Heart, Lung, and Blood Institute (NHLBI)
CompletedHemostasis in Sickle Cell Disease--Infancy to Adulthood
NCT00005703
National Heart, Lung, and Blood Institute (NHLBI)
CompletedPrevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center
NCT00005327
University of Southern California
CompletedNeuropsychological Studies of Children With Sickle Cell
NCT00005438
National Heart, Lung, and Blood Institute (NHLBI)
TerminatedBlood Donation--Immune Sequelae and Recruitment
NCT00005341
University of New Mexico
CompletedProspective Study of HIV Infection in Hemophiliacs
NCT00005309
Bloodworks
CompletedAnemia and Surgery: Indications For Transfusion
NCT00005308
National Heart, Lung, and Blood Institute (NHLBI)
CompletedIndices of Severity and Prognosis for Sickle Cell Disease
NCT00005467
National Heart, Lung, and Blood Institute (NHLBI)
CompletedVietnam Era Twin (VET) Registry
NCT00005126
National Heart, Lung, and Blood Institute (NHLBI)
CompletedEtiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data
NCT00005307
National Heart, Lung, and Blood Institute (NHLBI)
CompletedInvestigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
NCT00005300
National Heart, Lung, and Blood Institute (NHLBI)
CompletedAplastic Anemia Epidemiology: Incidence and Case-control
NCT00005682
National Heart, Lung, and Blood Institute (NHLBI)
CompletedErythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection
NCT00000587
Thomas Jefferson UniversityPhase 2
CompletedCerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell Center
NCT00005326
National Heart, Lung, and Blood Institute (NHLBI)
CompletedHepatitis Delta Infections in Hemophiliacs
NCT00005305
University of North Carolina, Chapel Hill
CompletedDelta Hepatitis and Liver Disease in Hemophiliacs
NCT00005304
Baylor College of Medicine
CompletedDrug Etiology of Aplastic Anemia and Related Dyscrasias
NCT00005302
National Heart, Lung, and Blood Institute (NHLBI)
CompletedMulti-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders
NCT00000597
National Heart, Lung, and Blood Institute (NHLBI)Phase 3
CompletedNational Health and Nutrition Examination Survey IV (NHANES (IV)
NCT00005154
National Heart, Lung, and Blood Institute (NHLBI)
CompletedCooperative Study of The Clinical Course of Sickle Cell Disease
NCT00005277
National Heart, Lung, and Blood Institute (NHLBI)